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Abstract: Dravet syndrome is a type of severe childhood epilepsy that responds poorly to current
anti-epileptic drugs. In recent years, zebrafish disease models with Scn1Lab sodium channel
deficiency have been generated to seek novel anti-epileptic drug candidates, some of which are
currently undergoing clinical trials. However, the spectrum of neuronal deficits observed following
Scn1Lab depletion in zebrafish larvae has not yet been fully explored. To fill this gap and gain a better
understanding of the mechanisms underlying neuron hyperexcitation in Scn1Lab-depleted larvae,
we analyzed neuron activity in vivo using combined local field potential recording and transient
calcium uptake imaging, studied the distribution of excitatory and inhibitory synapses and neurons
as well as investigated neuron apoptosis. We found that Scn1Lab-depleted larvae displayed recurrent
epileptiform seizure events, associating massive synchronous calcium uptakes and ictal-like local
field potential bursts. Scn1Lab-depletion also caused a dramatic shift in the neuronal and synaptic
balance toward excitation and increased neuronal death. Our results thus provide in vivo evidence
suggesting that Scn1Lab loss of function causes neuron hyperexcitation as the result of disturbed
synaptic balance and increased neuronal apoptosis.
Keywords: Dravet syndrome; Calcium imaging; Local field potential; Excitatory/inhibitory balance;
Apoptosis; In vivo imaging; Zebrafish; scn1Lab; Morpholino scn1LabAUG
1. Introduction
Dravet syndrome (DS) is a type of severe drug-resistant childhood epilepsy. It is associated with
several comorbidities, including intellectual disability, irreversible psychomotor deficits, behavioral
disorders, and high mortality at around 10 years of age [1,2]. DS is a genetic disease, caused in 80%
of cases by de novo loss of function mutations in the SCN1A gene encoding the alpha-1 subunit of
the main voltage-dependent sodium channel in inhibitory interneurons [3], whose synapses mainly
release GABA, a neurotransmitter that inhibits excitation of post-synaptic neurons [4].
Among animal models that have been developed in recent years, the zebrafish has proved to
be a versatile and powerful system for in vivo epilepsy research [5–7]. In particular, zebrafish larvae
with loss of function of the scn1Lab gene, one of the two zebrafish orthologs of SCN1A, have already
been used as animal models to find novel antiepileptic drug candidates, several of which are now
undergoing clinical trials [8–10].
However, while Scn1Lab-depleted larvae have been established as a bona fide epilepsy
model [7–15], the spectrum of neuronal deficits induced by the loss of function of this sodium channel
has not yet been fully explored. To fill this gap, we first combined transient calcium uptake imaging
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and local field potential recording to analyze neuron hyperactivity at whole brain levels in real time.
In Scn1Lab-depleted larvae, we observed recurrent events associating massive synchronous calcium
uptakes and ictal-like local field potential bursts characteristic of epileptiform seizures. Importantly,
we also observed that these larvae displayed a marked deficit in the number of inhibitory synapses,
together with a dramatic over-accumulation of excitatory ones, heavily disrupting the synaptic balance,
which was correlated with a shift in the neuronal population toward excitatory neurons. Last, we
observed that loss of function of this sodium channel caused increased neuronal apoptosis. Taken
together, our findings are evidence that Scn1Lab-depletion causes epileptiform seizures as a result of
brain development defects that include impaired synaptic balance and increased neuronal death.
2. Materials and Methods
2.1. Fish Maintenance and Transgenic Lines
Adult zebrafish were raised at 26.5 ◦C in standard aquaculture conditions with a 14 h light/10 h
dark cycle. Embryos collected by natural spawning were raised in E3 medium complemented with
0.002% methylene blue and kept at 28.5 ◦C. 0.003% phenylthiourea (PTU; Sigma) was added at 1 day
post-fertilization (dpf) to inhibit pigmentation. The mutant scn1Lab (didyS552) was a gift from Dr. Scott
Baraban (University of California, San Francisco, USA), the HuC:GCaMP5G transgenic line was a
gift from Dr. George Debrégeas (Laboratoire Jean Perrin, Paris) and the Gad1b:GFP; Vglut2a:DsRed
double transgenic line was a gift from Dr Germán Sumbre (IBENS, Paris).
All the animal experiments described in the present study were conducted at the French National
Institute of Health and Medical Research (INSERM) UMR 1141 in Paris in accordance with European
Union guidelines for the handling of laboratory animals (http://ec.europa.eu/environment/chemicals/
lab_animals/home_en.htm), and were approved by the Direction Départementale de la Protection des
Populations de Paris and the French Animal Ethics Committee under reference No. 2012-15/676-0069.
2.2. Morpholino
Antisense morpholino-oligonucleotide (MO) (5′-CTGAGCAGCCATATTGACATCCTGC-3′),
obtained from Gene Tools, was used to block the scn1Lab zebrafish mRNA translation One- to
two-cell embryos were injected with 1 pmol MO scn1LabAUG, 0.53 ng rhodamine B dextran and
0.1 mM KCl.
2.3. Locomotor Activity
Larvae locomotor activity (i.e., movement) was evaluated using the Zebrabox, an infrared
automated recording and tracking device supported by ZebraLab software (Viewpoint, Lyon, France).
Each 96-well plate containing 4 dpf control, morphant or mutant larvae in 200 µL E3 medium was
placed in the Zebrabox recording chamber. In all locomotion recording protocols, animal color was set
to dark and detection threshold to 15. After 45 min habituation in darkness, larvae were simultaneously
tracked for 25 min. Larvae movement in each well was computed as the sum of all pixels for which
intensity changed during the recording, and plotted as “acting units”.
2.4. Calcium Imaging
4 dpf zebrafish larvae were paralyzed using 300 µM pancuronium bromide (PB, Sigma) and
immobilized dorsal-side down at the center of a recording chamber in 1.2% low-melting agarose
covered with E3 medium containing 0.003% PTU and 300 µM PB. The chamber was then placed on
an inverted a Leica SP8 laser scanning confocal microscope equipped with a 20x/multi-immersion
0.75 objective. Calcium uptake events were detected by recording the fluorescence of a 512 × 512-pixel
image of a single focal plane at 2 Hz for 1 h. Fluorescence intensity of the optic tectum was measured
using ImageJ software. Fluorescence variations (∆F/F0) were calculated by subtracting the mean
fluorescence intensity of all frames and normalizing the mean fluorescence intensity of all frames.
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The fluorescence drift over time was corrected by subtracting the mean value of the lowest values
(all values under the median) within a 20 s sliding window around the point. All fluorescence increases
greater than 0.04 ∆F/F0 were considered as calcium events. Since the detection system may detect false
events, all of them were manually checked.
2.5. Local Field Potential Recording
4 dpf zebrafish larvae were paralyzed using 300 µM PB and immobilized, ventral-side down, in 2%
low-melting agarose covered with E3 medium containing 300 µM PB. A glass electrode (5–6 MΩ) filled
with artificial cerebrospinal fluid composed of 10 mM HEPES, 134 mM NaCl, 2.9 mM KCl, 2.1 mM
CaCl2, 1.2 mM MgCl2, 10 mM glucose; pH 7.8, was placed in the left neuropil of the optic tectum of the
larva. The recordings were performed for 1 h in a current clamp mode at 10 µs sampling interval and
with a 0.1 Hz high-pass filter, 1 kHz low-pass filter and digital gain at 10 (MultiClamp 700B amplifier,
Digidata 1400 digitizer, both Molecular Devices). Results were analyzed with the Clampfit software
(Molecular Devices, San José, CA, USA). Events were defined as every downward membrane potential
variation under -0.3 mV amplitude and lasting more than 100 ms.
2.6. Synapse Immunostaining
4 dpf control and morphant larvae were fixed with 4% formaldehyde for 1 h 30 min at room
temperature and stored at 4 ◦C in PBS containing 0.02% sodium azide. Fixed larvae were transferred
to 15% sucrose at 4 ◦C overnight and then embedded in 7.5% gelatin/15% sucrose, flash frozen in
isopentane at -45 ◦C and stored at -80 ◦C. When needed, frozen embedded larvae were cut into 20 µm
thick sections using a cryostat, mounted on Superfrost slides and stored at -20 ◦C until immunostaining.
For gephyrin, larvae were not fixed, but transferred in 15% sucrose for 1 h at room temperature,
anesthetized with 0.01% tricaine and embedded in 7.5% gelatin/15% sucrose. 20-µm-thick sections
were post-fixed for 10 min with 4% formaldehyde and treated with 0.25% trypsin diluted in PBS
for 2 min. Immunostaining was performed as follows. Sections were washed three times with PBS,
blocked and permeabilized with 0.2% gelatin/0.25% Triton diluted in PBS. Rabbit antibody anti-PSD-95
(Abcam, Ab18258, 1:200), an excitatory post-synaptic protein, or rabbit antibody anti-gephyrin (Abcam,
Ab185993, 1:100), an inhibitory post-synaptic protein, were added onto the sections, which were
incubated overnight at room temperature. Sections were washed several times and incubated with
anti-rabbit IgG Alexa 488 conjugated antibody (Molecular Probes, A-21206, 1:500), in the dark at room
temperature. After 1 h incubation, sections were washed and stained in the dark for 10 min with
0.3% DAPI. After a last wash, sections were mounted in Fluoromount medium and conserved at 4 ◦C
in the dark. Sections were imaged using a Leica SP8 laser scanning confocal microscope equipped
with a 40x/oil 1.3 objective. Optic tectum and telencephalon regions were captured at full resolution,
0.063 × 0.063 × 0.4 µm voxel size. Images were deconvoluted using AutoQuant (Media Cybernetics,
Rockville, MD, USA) software and processed using ImageJ software. PSD-95 and gephyrin puncta
were quantified using a semi-automated macro (Zsolt Csaba; Inserm UMR1141), which applied a
threshold to segment the image and select only the puncta ranging between 0.018 µm2 and 3.14 µm2.
The total number of PSD-95 or gephyrin puncta was finally divided by the surface area of interest to
obtain the density of PSD-95 and gephyrin signal in the optic tectum. All manual cell counts were
performed blind.
2.7. Identification and Counting of Inhibitory and Excitatory Neurons
3, 4 and 5 dpf larvae were anesthetized using 0.01% tricaine and embedded in 1.2% low-melting
agarose, ventral-side down, in a recording chamber covered with E3 medium containing 0.003% PTU
and 0.01% tricaine. The chamber was then placed under a Zeiss LSM 880 laser scanning confocal
microscope equipped with a WPApo 20x/1.0 objective. 52 slices spanning approximately 100 µm were
captured and processed using AutoQuant 3.1X (Media Cybernetics, Rockville, MD, USA). Gad1b
and Vglut2a positive neurons in the optic tectum were counted using Imaris MeasurementPro8.4.2
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(Bitplane, Zurich, Switzerland). Briefly, neurons were approximated as 7-µm-diameter spheres and
sorted by their fluorescence intensity.
2.8. Neuronal Death
Neuronal death was detected in living zebrafish brains using acridine orange (AO), which binds to
free nucleic acid. 4 dpf control and scn1Lab larvae were incubated for 20 min with 10 µM AO (VectaCell)
in E3 medium. Larvae were washed several times, paralyzed with 300 µM PB and embedded in 1.1%
low-melting agarose in the center of a 35 mm glass-bottom dish, covered with E3 medium containing
0.003% PTU and 300 µM PB. 100 µm brain stacks were acquired using a Leica SP8 laser confocal
scanning microscope equipped with a 20x/multi-immersion 0.75 objective. In addition, 4 dpf control
and morphant brains were dissected, fixed with 4% formaldehyde and stained with activated caspase-3
antibody. The brains were first washed with 0.1% triton in PBS, then permeabilized and blocked with
5% goat serum/1% Triton in PBS. Rabbit polyclonal antibody to activated caspase-3 (Abcam, Ab44976,
1:500) was added, which was incubated overnight at room temperature. Brains were washed several
times and incubated with an anti-rabbit IgG Alexa 488 conjugated antibody (Molecular Probes, A-21206
1:500), for 1 h at room temperature in the dark. Brains were finally washed, embedded in 1.1% agarose
in the center of a 35 mm glass-bottom dish and imaged using a Leica SP8 laser scanning confocal
microscope equipped with a 20x/multi-immersion 0.75 objective. All images were processed using
AutoQuant 3.1X (Media Cybernetics, Rockville, MD, USA) and ImageJ software.
2.9. Colocalization of Activated Caspase-3 Labeling with Inhibitory or Excitatory Neurons
4 dpf Tg[Gad1:GFP; Vglut2a:DsRed] larval brains were stained using activated caspase-3 antibody
followed by anti-rabbit IgG Cy5 conjugated antibody (Molecular Probes, A-10523,1:300) and imaged as
previously described. Images were processed using AutoQuant 3.1X (Media Cybernetics, Rockville,
MD, USA). Colocalization of activated caspase-3 signals with Gad1b or Vglut2a positive neurons was
assessed manually using ImageJ software.
2.10. Z-VAD Treatment
3 dpf control and scn1Lab larvae were incubated for 24 h with either vehicle or 300 µM Z-VAD-fmk
(Sigma), in E3 medium containing 1% dimethyl sulfoxide (DMSO). Dead cells were then labeled using
AO and imaged as previously described.
2.11. Statistics
Data were plotted and analyzed using GraphPad Prism 5. Data were checked for normality
using the d’Agostino and Pearson omnibus normality test with alpha set at 0.05. Data that did not
follow a normal distribution were compared with a Mann-Whitney test. Data that followed a normal
distribution were analyzed with Student’s two-tailed unpaired t-test with or without Welch’s correction
depending on the variance difference of each sample. Graphs show the mean and the SEM.
3. Results
3.1. Calcium Imaging Combined with LFP Recordings as Tools to Analyze Neuronal Activity in Vivo in
Scn1Lab-Depleted Zebrafish Larvae
As previously described, zebrafish embryos injected with 1 pmol scn1LabAUG
morpholino-oligonucleotide, hereafter referred to as scn1Lab morphants, and scn1Lab552/s552 mutants
displayed several highly penetrant phenotypes, including black appearance resulting from defective
pigment aggregation, failure to inflate their swim bladder, and, from 4 dpf onward, recurrent
spontaneous epileptiform seizures, reflected by a markedly increased swimming activity of the
larvae [8,10], (Figure S1). Importantly, since phenotypes observed in scn1Lab morphants (N = 904),
and particularly seizure number and intensity, were the same as those seen in scn1Labs552/s552 mutants
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(N = 192), we decided to use the former to further characterize the neuronal phenotypes associated
with loss of Scn1Lab function.
First, to confirm that the increased swimming activity observed in 4 dpf scn1Lab morphants did
correspond to bona fide epileptic seizures caused by the synchronous hyperexcitation of large neuron
populations, we generated zebrafish scn1Lab morphants that also carried the Tg[HuC:GCaMP5G]
transgene encoding a calcium-dependent fluorescent protein expressed under the control of the
pan-neuronal HuC promoter [16]. To record transient calcium uptakes associated with neuron
hyperexcitation during epileptiform seizures, we imaged the optic tectum of pancuronium-paralyzed
and agarose-immobilized 4 dpf larvae and simultaneously recorded forebrain local field potentials
(LFPs) (Figure 1A). Results show that scn1LabAUG morphants displayed recurrent spontaneous
transient calcium uptake events, events with ∆F/F0 > 0.04, (Figure 1E, F; p < 0.001) that also precisely
corresponded to multi-spike ictal-like discharges (correlation coefficient R2 = 0.772) (Figure 1G,H),
which were never seen in either non-injected larvae or control morphants (Figure 1D) (Figure S2). Thus,
in good agreement with previous results [8,10], 4 dpf Scn1Lab-depleted zebrafish larvae displayed
epileptiform seizures, which could be detected in vivo by both calcium imaging techniques and
LFP recordings.
3.2. Inhibitory/Excitatory Synaptic Balance is Disrupted in Scn1Lab-Depleted Larvae
Harmonious functioning of neuron networks relies on a finely tuned balance between excitatory
and inhibitory inputs [17]. Synapses, which are essential components of this balance, comprise both
excitatory and inhibitory subunits that release glutamate and GABA, respectively [18]. This balance is
impaired in neurological disorders such as epilepsy in which large populations of neurons display
synchronous hyperexcitation [19,20]. We recently showed that zebrafish gabra1-/- and depdc5-/- epileptic
mutants displayed markedly fewer inhibitory synapses compared to age-matched control larvae,
showing that these two mutants display brain development defects [21,22]. To determine whether
Scn1Lab deficiency also induced unbalanced excitatory/inhibitory post-synaptic outputs, we analyzed
and compared, by immunocytochemistry, the distribution of the two post-synaptic populations on brain
sections of 5 dpf control and Scn1Lab-depleted larvae, using anti-PSD-95 and anti-gephyrin antibodies,
which label excitatory and inhibitory post-synaptic terminals, respectively [23]. Quantification of the
two post-synaptic populations showed a marked increase in PSD-95 labeling (Figure 2B,C; p < 0.01)
combined with a clear decrease of that of gephyrin (Figure 1E,F; p < 0.01), in scn1LabAUG morphants,
compared to controls (Figure 2A,D). These data clearly show that depletion of Scn1Lab causes a marked
disruption of the synaptic balance, which is shifted toward excitation (Figure 2G; p < 0.01).
3.3. Distribution of Excitatory and Inhibitory Neurons in scn1Lab Model
We next assessed whether the defective excitatory/inhibitory synaptic balance seen in
Scn1Lab-depleted larvae could be related to an abnormal ratio of inhibitory and excitatory neurons.
To test this hypothesis, we used the double transgenic line Tg[Gad1b:GFP; Vglut2a:DsRed] that labels
inhibitory neurons with GFP and excitatory neurons with DsRed [24,25] as recipient line to generate
scn1LabAUG morphants (Figure 3). First, live imaging combined with quantitative image analysis
revealed that the total number of neurons is significantly decreased in scn1LabAUG morphants at 3 dpf
(Figure 3D; p < 0.05), 4 dpf (Figure 3G; p < 0.001) and 5 dpf (Figure 3J; p < 0.01) when compared to
age-matched controls. Next, we quantified the number of inhibitory (GFP+) and excitatory (DsRed+)
neurons at 3, 4 and 5 dpf in scn1LabAUG morphants and controls. Our results show that at 3 dpf,
the percentage of excitatory and inhibitory neurons was similar in Scn1Lab-depleted and control
larvae (Figure 3K). By contrast, the ratio of excitatory to inhibitory neurons was markedly increased at
4 dpf (Figure 3L; p < 0.001) and 5 dpf (Figure 3M; p < 0.01). It is of note that the ratio of excitatory to
inhibitory neurons did not change in control embryos between 3 and 5 dpf (Figure 3K,L,M).
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Figure 1. Correlation between LFP and calcium activity in scn1Lab model. (A) Schematic of the
experimental setup to simultaneously record local field potential and calcium activity of a larval zebrafish
brain. (B,C) Calcium images showing respectively the baseline activity (B) and the seizure activity (C).
The fluorescence intensity is color-coded as shown in the color bar below the images. (D,E) Representative
20 min calcium recording of immobilized and paralyzed 4 dpf control (D) (N = 9) and scn1Lab (E) (N = 9)
larvae. Each calcium event is shown with an orange arrowhead. (F) Number of events, calcium increases
greater that 0.04 ∆F/F0 amplitude, during 1 h recording. (G) Representative LFP, recorded in the left neuropil
of the optic tectum, and calcium traces, from the optic tectum, of a paralyzed and immobilized 4 dpf scn1Lab
larva. (H) Correlation between LFP and calcium events duration (n = 46). N = number of larvae and
n = number of events. Error bars on all graphs represent standard error of the mean (SEM). ***, p < 0.001.
p-value was determined using Student’s unpaired t-test.
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Figure 2. Defects of excitatory/inhibitory balance in the Scn1Lab-depleted larvae. (A,B) 20 µm coronal
sections of 5 dpf control (A) (N = 5, n = 15) and scn1Lab (B) (N = 5, n = 15) larvae stained with PSD-95,
an excitatory post-synaptic scaffolding protein. (D,E) 20 µm coronal sections of 5 dpf control (D)
(N = 5, n = 20) and scn1Lab (E) (N = 5, n = 19) larvae stained with gephyrin, an inhibitory post-synaptic
scaffolding protein. Images were acquired with a SP8 Leica laser scanning confocal microscope
equipped with a 40x/oil 1.3 objective. Scale bar 5 µm. (C,F) Quantification of PSD-95 (C) and gephyrin
(F) puncta density. (G) PSD-95/gephyrin puncta density ratio. N = number of larvae and n = number
of sections. Error bars on all graphs represent standard error mean (SEM). **, p < 0.01. p-values were
determined using the Mann-Whitney test.
3.4. Increased Neuron Apoptosis in Scn1Lab-Depleted Larvae
A large body of data gained from the analysis of neuronal tissues from human epileptic patients
and animal epilepsy models clearly indicates that both brief and prolonged seizures cause neuron
death through activation of both apoptosis and autophagy signaling pathways [26–28]. We therefore
investigated whether Scn1Lab depletion induced increased neuron apoptosis. We first used in vivo
labeling with acridine orange. Results showed that the number of apoptotic cells was markedly
increased in scn1LabAUG morphants compared to control larvae (Figure 4A,B,D; p < 0.001). To confirm
this result, we also visualized neuron apoptosis using immunocytochemistry and anti-activated
caspase-3 antibody In good agreement with acridine orange staining, a significant increase in the
number of activated caspase-3 positive cells were observed in the brain of Scn1Lab-depleted individuals
compared to control larvae (Figure 4E,F,G; p < 0.001).
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Figure 3. Evolution of the excitatory-inhibitory neuronal population in the scn1Lab model. (A1-3,B1-3) Dorsal
view of 3 dpf Tg[Gad1b:GFP; Vglut2a:DsRed] control (A1-3) (N = 8) and scn1Lab (B1-3) (N = 8) living larvae.
(A1,B1) Inhibitory neurons (Gad1b:GFP) in 3 dpf control (A1) and scn1Lab (B1) larvae. (A2,B2) Excitatory
neurons (Vglut2a:DsRed) in 3 dpf control (A2) and scn1Lab (B2) larvae. (A3,B3) Merged image of 3 dpf control
(A3) and scn1Lab (B3) larvae. (C) Dorsal view schematic of a 4 dpf larva. The red rectangle shows the region of
interest. (E1-3,F1-3) Dorsal view of 4 dpf Tg[Gad1b:GFP; Vglut2a:DsRed] control (E1-3) (N = 8) and scn1Lab
(F1-3) (N = 8) living larvae. (E1,F1) Inhibitory neurons (Gad1b:GFP) in 4 dpf control (E1) and scn1Lab (F1) larvae.
(E2,F2) Excitatory neurons (Vglut2a:DsRed) in 4 dpf control (E2) and scn1Lab (F2) larvae. (E3,F3) Merged image
of 4 dpf control (E3) and scn1Lab (F3) larvae. (H1-3,I1-3) Dorsal view of 5 dpf Tg[Gad1b:GFP; Vglut2a:DsRed]
control (H1-3) (N = 8) and scn1Lab (I1-3) (N = 8) living larvae. (H1,I1) Inhibitory neurons (Gad1b:GFP) in 5 dpf
control (H1) and scn1Lab (I1) larvae. (H2,I2) Excitatory neurons (Vglut2a:DsRed) in 5 dpf control (H2) and
scn1Lab (I2) larvae. (H3,I3) Merged image of 5 dpf control (H3) and scn1Lab (I3) larvae. (D,G,J) Number of
neurons in control and scn1Lab larvae at 3 dpf (D), 4 dpf (G) and 5 dpf (J). (K,L,M) Number of inhibitory
and excitatory neurons in control and scn1Lab larvae at 3 dpf (K), 4 dpf (L) and 5 dpf (M). All images are
representative 20 µm stacks acquired using LSM 880 Zeiss laser scanning confocal microscope equipped with a
WPApo 20x/1.0 objective. Scale bar 40µm. N = number of embryos. Error bars on all graphs represent standard
error mean (SEM). * p < 0.05; ** p < 0.01; ***,p < 0.001 indicate a statistically significant difference between
control and scn1Lab larvae. Statistically significant difference between inhibitory and excitatory neuronal
population is indicated as $$, p < 0.01; $$$, p < 0.001. p-values were determined using Student’s unpaired t-test.
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Figure 4. Increased neuronal death in Scn1Lab-depleted larvae. (A,B) Dorsal view of 4 dpf living control (A)
(N = 15) and scn1Lab (B) (N = 15) larvae stained with acridine orange; 100µm stack. Scale bar 40µm. (C) Dorsal
view schematic of 4 dpf larva. The red rectangle shows the region of interest for global cell death quantification.
(D) Number of acridine orange-positive cells in 4 dpf brain. (E,F) Dorsal view of 4 dpf control (E) (N = 24)
and scn1Lab (F) (N = 22) brain stained with activated caspase-3 antibody; 100 µm stack. Scale bar 40 µm.
(G) Number of activated caspase-3-positive cells in 4 dpf brain. (H-I) Dorsal view of 4 dpf Z-VAD-treated
control (H) (N = 18) and scn1Lab (I) (N = 16) larvae stained with acridine orange; 100 µm stack. Scale bar
40 µm. (J) Number of acridine orange-positive cells in 4 dpf brain. (K) Dorsal view schematic of 4 dpf larva.
The red rectangle shows the region of interest for activated caspase-3 signal colocalization with inhibitory
and excitatory neurons quantification. (L) Number of inhibitory (Gad1b:GFP) and excitatory (Vglut2a:DsRed)
neurons also showing activated caspase-3 labelling in control and scn1Lab larvae. (M1-4, N1-4) Dorsal view
of 4 dpf Tg[Gad1b:GFP; Vglut2a:DsRed] control (M1-4) (N = 14) and scn1Lab (N1-4) (N = 14) brain stained
with activated caspase-3 antibody; representative 15 µm stack. Scale bar 10 µm. (M1,N1) Inhibitory neurons
(Gad1b:GFP) in control (M1) and scn1Lab (N1) larvae. (M2,N2) Excitatory neurons (Vglut2a:DsRed) in control
(M2) and scn1Lab (N2) larvae. (M3,N3) Activated caspase-3 staining in control (M3) and scn1Lab (N3) larvae.
(M4,N4) Merged images of control (M4) and scn1Lab (N4) larvae. Excitatory neurons with activated caspase-3
expression are shown by arrowheads, while inhibitory neurons with activated caspase-3 expression are shown
by arrows. Images were all acquired with an SP8 Leica laser scanning confocal microscope equipped with
40x/water 1.1 objective. N = number of embryos. Error bars on all graphs represent standard error mean
(SEM). *, p < 0.05; ***, p < 0.001 indicate a statistically significant difference between control and scn1Lab larvae.
A statistically significant difference between inhibitory and excitatory neuronal population is indicated as $$$,
p < 0.001. p-values were determined using Student’s unpaired t-test.
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Because Scn1Lab-depleted larvae showed an increased number of apoptotic cells, we next
investigated whether this apoptosis was caspase-dependent. To test this hypothesis, we used Z-VAD,
a cell-permeable caspase inhibitor that reversibly binds to the catalytic site of caspase proteases and
inhibits their activity [29]. We incubated 3 dpf Scn1Lab-depleted and control embryos for 24 h in
E3 medium containing 300 µM Z-VAD and 1% DMSO [30–32]. As negative control, age-matched
Scn1Lab-depleted and control larvae were incubated for 24 h in E3 medium containing 1% DMSO.
Cell death was assessed using acridine orange staining combined with real-time confocal imaging.
Our data show that following Z-VAD treatment, the number of acridine orange-positive cells increased
in both control (Figure 4A,H) and Scn1Lab-depleted larvae (Figure 4B,I), suggesting that Z-VAD had
no effect on cell apoptosis in scn1Lab model.
We next examined whether apoptotic death occurred in excitatory or inhibitory neurons. To do this,
4 dpf Tg[Gad1b:GFP; Vglut2a:DsRed], Scn1Lab-depleted and Tg[Gad1b:GFP; Vglut2a:DsRed] control
larvae were fixed and analyzed by immunohistochemistry using anti-activated caspase-3 antibody.
In both Scn1Lab-depleted (Figure 4N1-4) and control (Figure 4M1-4) Tg[Gad1b:GFP; Vglut2a:DsRed]
larvae, we observed a greater number of excitatory neurons expressing activated caspase-3 than
inhibitory ones. Quantification of the number of inhibitory and excitatory neurons colocalizing with
activated caspase-3 expression, confirmed that neuronal death specifically affects excitatory neurons
(Figure 4L; Gad1b+-Act-Casp3+ vs Vglut2a+-Act-Casp3+ controls: p < 0.001; Gad1b+-Act-Casp3+ vs
Vglut2a+-Act-Casp3+ scn1Lab: p < 0.001).
4. Discussion
Dravet syndrome (DS) is a catastrophic childhood epilepsy with multiple comorbidities, which
include severe intellectual disability, impaired social development, persistent drug-resistant seizures
and high risk of sudden unexpected death in epilepsy (SUDEP) [1,33]. In recent years, thanks to
vertebrate genome conservation, full genome sequencing and readily available molecular tools and
techniques, zebrafish has become a powerful and versatile animal model for studying genetic forms of
epilepsy and also to screen for novel anti-epileptic drugs [8,10,22]. Among epilepsy mutants, zebrafish
larvae with loss of function of the scn1Lab gene, one of the two zebrafish orthologs of SCN1A, was
instrumental to identify drugs alleviating seizures in refractory epilepsy [8,10]. However, despite
the large number of studies that have used Scn1Lab-depleted zebrafish mutants and morphants,
the neuronal phenotypes induced by loss of function of this sodium channel encoding gene have not
yet been fully investigated.
Using combined in vivo calcium imaging and local field potential (LFP) in the optic tectum of
zebrafish models of DS, we observed a full correlation between calcium activity and neuronal activity,
with both techniques consistently showing generalized ictal-like seizure events. Recent studies showed
a correlation between calcium and local field potential activities using an acute PTZ seizure model in
zebrafish [14]. To our knowledge, this is the first time that a correlation between calcium and electrical
activities has been reported in a genetic model of epilepsy. This finding is important for research on
epilepsy because it validates the use of calcium activity to monitor the dynamics of seizures at the scale
of an entire vertebrate brain. In particular, calcium imaging provides a unique opportunity to follow
the dynamics of seizures spatiotemporally, from the initiation site to propagation through the brain.
We focused on excitatory and inhibitory synapses by studying two important proteins that are
markers of synaptic integrity, PSD-95 and gephyrin [23]. PSD-95, by its PDZ domains, serves as a
scaffolding protein with a docking site for signaling proteins clustering around NMDA- and AMPA-
type glutamate receptors, which are crucial for excitatory neurotransmission and synaptic plasticity [34].
Gephyrin is a core scaffolding protein, the postsynaptic component of inhibitory synapses, and it
controls the formation and plasticity of inhibitory synapses through regulation of GABAA and glycine
receptors [35]. In the present study, we demonstrated that levels of PSD-95 and gephyrin are modified
in zebrafish models of DS. Indeed, by studying the distribution of excitatory and inhibitory neurons
during development, we have shown that at 3 days of development, the ratio of excitatory to inhibitory
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neurons was comparable between Scn1Lab-depleted larvae and their sibling controls. Interestingly,
from 4 days of development onward, we observed that the proportion of excitatory neurons increased
when compared to that of inhibitory neurons in scn1LabAUG morphants, while this ratio remained
unchanged in control embryos. This specific neuronal death may therefore explain the severe gephyrin
signal loss observed in the scn1Lab model. Moreover, the increase in excitatory neurons detected
from 4 dpf onward probably corresponds to the beginning of the disease in Scn1Lab-depleted larvae.
Interestingly, these data are in good agreement with our results obtained using LFP recording and
calcium imaging, showing that the peak of seizures was observable at 4 and 5 dpf in Scn1Lab-depleted
larvae [8].
Previous studies have shown that subtle changes in synaptic structure or composition, which
alter synaptic plasticity and functional responses, most likely contribute to synaptic dysfunction [36].
Differences in key synaptic protein levels can provide information about the excitatory/inhibitory
components of neurotransmission that might be disturbed or impaired during epileptogenesis [37].
It is known that the balance between excitatory and inhibitory synapses is impaired in patients with
epilepsy [20]. These results are also in line with the observation of Stief et al. (2007) in another model
of epilepsy in rats, that the balance between excitatory and inhibitory synapses is shifted toward an
over-excited state [19].
Our results using a zebrafish model of DS show an increase in apoptotic cells as previously
observed in models of epilepsy [26–28]. We have also shown that treatment of Scn1Lab-depleted
larvae with Z-VAD fails to inhibit cell death, suggesting that Z-VAD has no effects on cell apoptosis in
scn1Lab model. However, we cannot exclude the possibility that Z-VAD may cause cellular toxicity in
scn1lab model thus masking its protective effect. Unexpectedly, colocalization analysis of inhibitory
and excitatory neurons with activated caspase-3 staining at 4 dpf revealed that cell death preferentially
targeted excitatory neurons. This could be explained by the fact that during seizures, excitatory
neurons are hyper-excited and eventually die. In relation to this hypothesis, we sometimes observed
during in vivo calcium imaging, using larvae from transgenic line Tg[HuC:GCaMP5G; scn1Lab], that
some neurons became hyper-excited, as revealed by the over-expression of GFP labeling, and die
(personal observations).
Our study emphasizes that the DS models are not only a powerful new tool for finding new
antiepileptic drug candidates that could alleviate refractory seizures [8–10], but more importantly, they
also display neurodevelopmental alterations characteristic of epileptic brains, such as the imbalance
of excitatory/inhibitory synapses and apoptosis. Our data thus provide in vivo evidence for a
developmental aspect of epileptogenesis that had been hypothesized [38,39], but not definitely proved.
Our study shows that DS is a disease of the central nervous system, and it calls for a closer focus on
neurodevelopmental defects leading to severe comorbidities in DS (speech deficiency, autism, etc.)
and not just on managing refractory seizures with antiepileptic drugs. More research is needed to
understand the exact neurodevelopmental abnormalities causing epilepsy and to correct them as
early as possible, rather than only treating them symptomatically at later stages. In the same way,
we showed previously that gabra1 loss of function (generalized epilepsy) induced developmental
alterations, in particular for the establishment of GABAergic networks throughout the brain [22].
The findings reported here shed light on the neurobiological changes that occur in the early stages
of DS, and are a promising start in understanding the neurodevelopmental origins of DS and finding
potential treatments to restore normal brain development at earlier stages of the disease.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4409/8/10/1199/s1,
Figure S1: Comparison of scn1LabAUG morphant and scn1Labs552/s552 mutant morphology and locomotor
activity, and http://www.mdpi.com/2073-4409/8/10/1199/s2, Figure S2: Neuronal activity of scn1Lab model.
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